FASTinov will be present at the SEIMC congress in Santiago de Compostela, Spain, on 1-3 June 2023
FASTinov will be present at the upcoming 26th Congress of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica, which will take place in the Palacio de Congresos y Exposiciones de Galicia, in Santiago de Compostela, Spain on June 1-3.
The company has recently started the commercialization of its ultra-rapid Antibiotic Susceptibility Testing technology capable of establishing phenotypic susceptibility in less than two hours directly from blood cultures.
“FASTinov’s goal is to revolutionize antimicrobial susceptibility testing in a way that was never done before, allowing the output of results on the same day the blood cultures turn positive. The company’s commitment to improve clinical microbiology drives us to keep in touch with clinicians all around the world in order to better understand their specific needs and how our technology can be integrated to potentially improve the bloodstream infection diagnosis response. Attending SEIMC is the perfect opportunity to do so in a country that has leading experts in the field of Antimicrobial Resistance.”
FASTinov will be at stand 32. Come visit us!
FASTinov has developed ultra-rapid, phenotypic antibiotic susceptibility tests for bloodstream infections that deliver antibiograms in less than 2 hours, based upon patented technologies. The company is based in Porto, Portugal.
For press inquiries, please contact: firstname.lastname@example.org
- For press inquiries, please contact: email@example.com
Share with friends